The Regueiro Report
Low-Dose Aspirin During Pregnancy for Women With IBD, Guselkumab for Moderate to Severe UC
The first study in The Regueiro Report this month focuses on the intersection of pregnancy and inflammatory bowel ...
APRIL 24, 2025

Upadacitinib Versus Tofacitinib in UC; Etrasimod for Proctitis
Prospective studies that directly compare the efficacy of two different medications remain rare in our field, ...
NOVEMBER 15, 2024

Head-to-Head IL Inhibitors, SPICY Trial Surgical Techniques in CD
In this edition of The Regueiro Report, I highlight a head-to-head comparison of two drugs and another study ...
OCTOBER 16, 2024

A Miss for FMT in Ulcerative Colitis, Additional Upadacitinib Benefits in Crohn’s
This month’s report looks at two distinct issues: fecal microbiota transplantation and upadacitinib.
SEPTEMBER 17, 2024

Postoperative Considerations in IBD
This month, we look at two examples of how to manage postoperative inflammatory bowel disease.
MARCH 14, 2024

First-Line Surgery for CD and Possibility of Precision Medicine for UC
This month, Miguel Regueiro, MD, examines whether surgery should be the first-line treatment for some with ...
FEBRUARY 16, 2024

The Regueiro Report: Focus on CRC
In this installment, Miguel Regueiro, MD, a professor of medicine and the chair of the Department of ...
NOVEMBER 20, 2020

The Regueiro Report: February
In this installment of The Regueiro Report, Miguel Regueiro, MD, the chair of the Department of Gastroenterology, ...
MARCH 6, 2020
